Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Shawver Laura
Director at ARS Pharmaceuticals. Filing since 9 Nov 2022.
CIK 0001551891
Company
Date
Role
Action
Shares
Amount
Of holding
SPRY
ARS Pharmaceuticals, Inc.
7 Apr 2025
Director
Sold on a plan
50,002
$615.07K
19.2%
SPRY
ARS Pharmaceuticals, Inc.
6 Mar 2025
Director
Sold on a plan
49,600
$556.05K
19.1%
SPRY
ARS Pharmaceuticals, Inc.
5 Mar 2025
Director
Sold on a plan
400
$4.40K
0.2%
SPRY
ARS Pharmaceuticals, Inc.
3 Feb 2025
Director
Sold on a plan
50,000
$615.57K
19.2%
SPRY
ARS Pharmaceuticals, Inc.
6 Jan 2025
Director
Sold on a plan
50,000
$555.07K
19.2%
SPRY
ARS Pharmaceuticals, Inc.
4 Dec 2024
Director
Sold on a plan
14,772
$203.11K
6.6%
SPRY
ARS Pharmaceuticals, Inc.
3 Dec 2024
Director
Sold on a plan
87,984
$1.17M
29.5%
SPRY
ARS Pharmaceuticals, Inc.
2 Dec 2024
Director
Sold on a plan
97,244
$1.32M
31.6%
SPRY
ARS Pharmaceuticals, Inc.
1 Sep 2023
Director
Sold on a plan
100,000
$770.52K
32.2%
SPRY
ARS Pharmaceuticals, Inc.
4 Aug 2023
Director
Sold on a plan
18,897
$133.47K
8.2%
SPRY
ARS Pharmaceuticals, Inc.
3 Aug 2023
Director
Sold on a plan
26,107
$183.02K
11.0%
SPRY
ARS Pharmaceuticals, Inc.
2 Aug 2023
Director
Sold on a plan
36,281
$257.26K
14.7%
SPRY
ARS Pharmaceuticals, Inc.
1 Aug 2023
Director
Sold on a plan
18,715
$134.58K
8.2%
SPRY
ARS Pharmaceuticals, Inc.
7 Jul 2023
Director
Sold at will
8,858
$56.37K
4.0%
SPRY
ARS Pharmaceuticals, Inc.
6 Jul 2023
Director
Sold at will
33,510
$212.55K
13.7%
SPRY
ARS Pharmaceuticals, Inc.
5 Jul 2023
Director
Sold at will
31,112
$199.55K
12.9%
SPRY
ARS Pharmaceuticals, Inc.
3 Jul 2023
Director
Sold at will
26,520
$178.35K
11.2%
SPRY
ARS Pharmaceuticals, Inc.
2 Jun 2023
Director
Sold on a plan
26,941
$187.24K
11.4%
SPRY
ARS Pharmaceuticals, Inc.
1 Jun 2023
Director
Sold on a plan
73,059
$496.80K
25.8%
SPRY
ARS Pharmaceuticals, Inc.
9 May 2023
Director
Sold on a plan
42,900
$227.80K
16.9%
SPRY
ARS Pharmaceuticals, Inc.
8 May 2023
Director
Sold on a plan
57,100
$351.74K
21.4%
SPRY
ARS Pharmaceuticals, Inc.
9 Nov 2022
Director
Sold on a plan
43,896
$201.04K
17.3%
22 decisions on file.
